SNCA and Parkinson disease: Although PD-related alterations in methylation status in intron 1 is controversial [43,44,45,46,47,48,49,50,51], the induction of robust hypermethylation of SNCA CpG island results in a reduction in SNCA expression, which may be exploited as a therapeutic approach to prevent pathogenic αS accumulation [52].